Zacks Investment Research notes that EndoChoice has received an average one-year price target of $19.67 from analysts, according to an Intercooler report.
Here are four points:
1. Zacks recently lowered EndoChoice from a "hold" rating to a "sell" rating.
2. EndoChoice has a 52-week low of $3.70 and a 52-week high of $19.69.
3. The company has a 50-day moving average price of $5.95 and a 200-day moving average price of $10.47.
4. The firm's market capitalization is $108.35 million.